Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ...Middle East

PR Newswire - News
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., March 6, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective March 1, 2024, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 2,615 shares...

Hence then, the article about blueprint medicines announces inducement grants under nasdaq listing rule 5635 c 4 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) )

Apple Storegoogle play

Last updated :

Also on site :